Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ... Autophagy 8 (4), 445-544, 2012 | 13554* | 2012 |
RB and cell cycle progression C Giacinti, A Giordano Oncogene 25 (38), 5220-5227, 2006 | 1636 | 2006 |
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle A Koff, A Giordano, D Desai, K Yamashita, JW Harper, S Elledge, ... Science 257 (5077), 1689-1694, 1992 | 1444 | 1992 |
Cell cycle kinases as therapeutic targets for cancer S Lapenna, A Giordano Nature reviews Drug discovery 8 (7), 547-566, 2009 | 1141 | 2009 |
Recruitment of p300/CBP in p53-dependent signal pathways ML Avantaggiati, V Ogryzko, K Gardner, A Giordano, AS Levine, K Kelly Cell 89 (7), 1175-1184, 1997 | 935 | 1997 |
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells A Giordano, U Galderisi, IR Marino Journal of cellular physiology 211 (1), 27-35, 2007 | 888 | 2007 |
Cell cycle and apoptosis B Pucci, M Kasten, A Giordano Neoplasia 2 (4), 291-299, 2000 | 772 | 2000 |
Curcumin and cancer A Giordano, G Tommonaro Nutrients 11 (10), 2376, 2019 | 760 | 2019 |
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer V Esposito, A Baldi, A De Luca, AM Groger, M Loda, GG Giordano, ... Cancer research 57 (16), 3381-3385, 1997 | 596 | 1997 |
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer TK MacLachlan, N Sang, A Giordano Critical Reviews™ in Eukaryotic Gene Expression 5 (2), 1995 | 440 | 1995 |
Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (∗) W Yuan, G Condorelli, M Caruso, A Felsani, A Giordano Journal of Biological Chemistry 271 (15), 9009-9013, 1996 | 403 | 1996 |
Advantages and limitations of microarray technology in human cancer G Russo, C Zegar, A Giordano Oncogene 22 (42), 6497-6507, 2003 | 402 | 2003 |
Role of p53 in the regulation of cellular senescence M Mijit, V Caracciolo, A Melillo, F Amicarelli, A Giordano Biomolecules 10 (3), 420, 2020 | 398 | 2020 |
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ... European journal of clinical pharmacology 67, 507-519, 2011 | 396 | 2011 |
p300 and CBP: partners for life and death A Giordano, ML Avantaggiati Journal of cellular physiology 181 (2), 218-230, 1999 | 382 | 1999 |
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ... Endocrine-related cancer 12 (4), 721-747, 2005 | 378 | 2005 |
Detection and characterization of CD133+ cancer stem cells in human solid tumours V Tirino, V Desiderio, R d'Aquino, F De Francesco, G Pirozzi, U Galderisi, ... PloS one 3 (10), e3469, 2008 | 371 | 2008 |
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells A Giordano, P Whyte, E Harlow, BR Franza Jr, D Beach, G Draetta Cell 58 (5), 981-990, 1989 | 345 | 1989 |
p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription PL Puri, ML Avantaggiati, C Balsano, N Sang, A Graessmann, A Giordano, ... The EMBO journal, 1997 | 344 | 1997 |
Cell cycle regulation and neural differentiation U Galderisi, FP Jori, A Giordano Oncogene 22 (33), 5208-5219, 2003 | 340 | 2003 |